Literature DB >> 12522098

Comparison of signalling mechanisms involved in rat mesenteric microvessel contraction by noradrenaline and sphingosylphosphorylcholine.

Christoph Altmann1, Veronika Steenpass, Peter Czyborra, Peter Hein, Martin C Michel.   

Abstract

1 We have compared the signalling mechanisms involved in the pertussis toxin-sensitive and -insensitive contraction of rat isolated mesenteric microvessels elicited by sphingosylphosphorylcholine (SPC) and noradrenaline (NA), respectively. 2 The phospholipase D inhibitor butan-1-ol (0.3%), the store-operated Ca(2+) channel inhibitor SK>F 96,365 (10 microM), the tyrosine kinase inhibitor genistein (10 microM), and the src inhibitor PP2 (10 microM) as well as the negative controls (0.3% butan-2-ol and 10 microM diadzein and PP3) had only little effect against either agonist. 3 Inhibitors of phosphatidylinositol-3-kinase (wortmannin and LY 294,002, 10 microM each) or of mitogen-activated protein kinase kinase (PD 98,059 and U 126, 10 microM each) did not consistently attenuate NA- and SPC-induced contraction as compared to their vehicles or negative controls (LY 303,511 or U 124). 4 The phospholipase C inhibitor U 73,122 (10 microM) markedly inhibited the SPC- and NA-induced contraction (70% and 88% inhibition of the response to the highest NA and SPC concentration, respectively), whereas its negative control U 73,343 (10 microM) caused only less than 30% inhibition. 5 The rho-kinase inhibitors Y 27,632 (10 microM) and fasudil (30 microM) caused a rightward-shift of the NA concentration-response curve by 0.7-0.8 log units and reduced the response to 10 microM SPC by 88% and 83%, respectively. 6 These data suggest that SPC and NA, while acting on different receptors coupling to different G-protein classes, elicit contraction of rat mesenteric microvessels by similar signalling pathways including phospholipase C and rho-kinase.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12522098      PMCID: PMC1573654          DOI: 10.1038/sj.bjp.0705028

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  43 in total

1.  Modulation of noradrenaline-induced microvascular constriction by protein kinase inhibitors.

Authors:  C Fetscher; H Chen; R F Schäfers; G Wambach; G Heusch; M C Michel
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2001-01       Impact factor: 3.000

Review 2.  Rho-Rho-kinase pathway in smooth muscle contraction and cytoskeletal reorganization of non-muscle cells.

Authors:  Y Fukata; M Amano; K Kaibuchi
Journal:  Trends Pharmacol Sci       Date:  2001-01       Impact factor: 14.819

3.  Specificity and mechanism of action of some commonly used protein kinase inhibitors.

Authors:  S P Davies; H Reddy; M Caivano; P Cohen
Journal:  Biochem J       Date:  2000-10-01       Impact factor: 3.857

4.  Rho-kinase inhibitors prevent agonist-induced vasospasm in human internal mammary artery.

Authors:  T J Batchelor; J R Sadaba; A Ishola; P Pacaud; C M Munsch; D J Beech
Journal:  Br J Pharmacol       Date:  2001-01       Impact factor: 8.739

5.  Lysosphingolipid receptor-mediated diuresis and natriuresis in anaesthetized rats.

Authors:  A Bischoff; D Meyer Zu Heringdorf; K H Jakobs; M C Michel
Journal:  Br J Pharmacol       Date:  2001-04       Impact factor: 8.739

6.  In vitro and in vivo uroselectivity of B8805-033, an antagonist with high affinity at prostatic alpha1A- vs. alpha1B- and alpha1D-adrenoceptors.

Authors:  M Eltze; R Boer; M C Michel; P Hein; R Testa; W R Ulrich; N Kolassa; K H Sanders
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2001-06       Impact factor: 3.000

7.  Involvement of Rho-kinase in hypertensive vascular disease: a novel therapeutic target in hypertension.

Authors:  Y Mukai; H Shimokawa; T Matoba; T Kandabashi; S Satoh; J Hiroki; K Kaibuchi; A Takeshita
Journal:  FASEB J       Date:  2001-04       Impact factor: 5.191

8.  Sphingosine-1-phosphate reduces rat renal and mesenteric blood flow in vivo in a pertussis toxin-sensitive manner.

Authors:  A Bischoff; P Czyborra; D Meyer Zu Heringdorf; K H Jakobs; M C Michel
Journal:  Br J Pharmacol       Date:  2000-08       Impact factor: 8.739

Review 9.  Sphingosine 1-phosphate signalling in mammalian cells.

Authors:  S Pyne; N J Pyne
Journal:  Biochem J       Date:  2000-07-15       Impact factor: 3.857

10.  Sphingosylphosphorylcholine induces Ca(2+)-sensitization of vascular smooth muscle contraction: possible involvement of rho-kinase.

Authors:  N Todoroki-Ikeda; Y Mizukami; K Mogami; T Kusuda; K Yamamoto; T Miyake; M Sato; S Suzuki; H Yamagata; Y Hokazono; S Kobayashi
Journal:  FEBS Lett       Date:  2000-09-29       Impact factor: 4.124

View more
  9 in total

1.  Role of the PKC/CPI-17 pathway in enhanced contractile responses of mesenteric arteries from diabetic rats to alpha-adrenoceptor stimulation.

Authors:  Irem Mueed; Lili Zhang; Kathleen M MacLeod
Journal:  Br J Pharmacol       Date:  2005-12       Impact factor: 8.739

Review 2.  Signal transduction underlying the vascular effects of sphingosine 1-phosphate and sphingosylphosphorylcholine.

Authors:  Denise G Hemmings
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2006-04       Impact factor: 3.000

Review 3.  Cardiovascular effects of sphingosine-1-phosphate and other sphingomyelin metabolites.

Authors:  Astrid E Alewijnse; Stephan L M Peters; Martin C Michel
Journal:  Br J Pharmacol       Date:  2004-10-25       Impact factor: 8.739

4.  Sphingolipids differentially regulate mitogen-activated protein kinases and intracellular Ca2+ in vascular smooth muscle: effects on CREB activation.

Authors:  Fiona A Mathieson; Graeme F Nixon
Journal:  Br J Pharmacol       Date:  2006-02       Impact factor: 8.739

5.  Phospholipase C-delta1 modulates sustained contraction of rat mesenteric small arteries in response to noradrenaline, but not endothelin-1.

Authors:  Christopher J Clarke; Simon Forman; James Pritchett; Vasken Ohanian; Jacqueline Ohanian
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-06-20       Impact factor: 4.733

Review 6.  Signal transduction underlying the control of urinary bladder smooth muscle tone by muscarinic receptors and beta-adrenoceptors.

Authors:  Elfaridah P Frazier; Stephan L M Peters; Alan S Braverman; Michael R Ruggieri; Martin C Michel
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-12-04       Impact factor: 3.000

7.  Augmented sphingosylphosphorylcholine-induced Ca2+-sensitization of mesenteric artery contraction in spontaneously hypertensive rat.

Authors:  Sung-Kyung Ryu; Duck Sun Ahn; Young-Eun Cho; Soo-Kyung Choi; Young-Hwan Kim; Kathleen G Morgan; Young-Ho Lee
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2006-03-07       Impact factor: 3.000

8.  Sphingosylphosphorylcholine potentiates vasoreactivity and voltage-gated Ca2+ entry via NOX1 and reactive oxygen species.

Authors:  Yasin Shaifta; Vladimir A Snetkov; Jesus Prieto-Lloret; Greg A Knock; Sergey V Smirnov; Philip I Aaronson; Jeremy P T Ward
Journal:  Cardiovasc Res       Date:  2015-02-06       Impact factor: 10.787

9.  Src family tyrosine kinases mediate contraction of rat isolated tail arteries in response to a hyposmotic stimulus.

Authors:  Sumangali Wijetunge; Alun D Hughes
Journal:  J Hypertens       Date:  2007-09       Impact factor: 4.844

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.